$69.14 +1.06 (%) AbbVie Inc - NYSE

Jul. 27, 2015 | 01:10 PM

Partner Headlines

  1. Biogen's Big-Volume Plunge Marks End Of 5-Year Run

    IBD | Jul. 24, 2015 | 13:26PM EST
  2. Biogen Plunges On Slashed Guidance; AbbVie Q2 Mixed

    IBD | Jul. 24, 2015 | 11:44AM EST
  3. Amazon Surges, Major Averages Set for Weekly Loss

    FoxBusiness | Jul. 24, 2015 | 09:30AM EST
  4. AbbVie Posts Upbeat Q2 Earnings, But Sales Miss Expectations

    Benzinga | Jul. 24, 2015 | 08:36AM EST
  5. Earnings Scheduled For July 24, 2015

    Benzinga | Jul. 24, 2015 | 04:51AM EST
  6. 10 Must Watch Stocks for Today

    Benzinga | Jul. 24, 2015 | 04:04AM EST
  7. Stocks Extend Losses; Amazon, Visa Headline After-Hours Action

    IBD | Jul. 23, 2015 | 17:06PM EST
  8. Illumina Breaches Key Level On Q2 Sales Miss

    IBD | Jul. 22, 2015 | 16:54PM EST
  9. What's Coming For Large-Cap Pharma Stocks This Earnings Season?

    Benzinga | Jul. 22, 2015 | 16:13PM EST
  10. Earnings Loom For Handful Of Top Big Cap 20 Stocks

    IBD | Jul. 20, 2015 | 18:50PM EST
  11. 6 Big-Cap Drugmakers Reporting Earnings Next Week

    IBD | Jul. 18, 2015 | 08:02AM EST
  12. Gilead's Fantastic Growth Expected To Slow

    IBD | Jul. 17, 2015 | 18:48PM EST
  13. It's Not Too Late To Buy Gilead Sciences

    GuruFocus | Jul. 17, 2015 | 12:01PM EST
  14. Fitbit Leads Trio Of Hot Health-Related IPO Stocks

    IBD | Jul. 15, 2015 | 17:50PM EST
  15. Top World Stocks In Bases Or Buy Range As Greece Votes

    IBD | Jul. 15, 2015 | 17:50PM EST
  16. Johnson & Johnson Profit Dips

    IBD | Jul. 14, 2015 | 18:54PM EST
  17. J&J Earnings Beat Views As Pharma Leads Way Again

    IBD | Jul. 14, 2015 | 11:18AM EST
  18. Big Cap 20: Biotech Red-Hot As Medicals Stay Dominant

    IBD | Jul. 13, 2015 | 18:43PM EST
  19. Allergan, Celgene Break Out As Other Medicals Base

    IBD | Jul. 13, 2015 | 18:43PM EST
  20. Don't Count Out Top Biotechs — They Still Got Game

    IBD | Jul. 10, 2015 | 18:05PM EST
  21. Juno, Celgene Lead 5 Top Biotechs Nearing Buy Point

    IBD | Jul. 1, 2015 | 17:43PM EST
  22. Can Hepatitis B Be A Blockbuster Bug?

    IBD | Jul. 1, 2015 | 08:02AM EST
  23. Enanta is growing thanks to collaborations.

    GuruFocus | Jun. 29, 2015 | 17:16PM EST
  24. Evercore ISI Analyst Breaks Down Amgen's IPR Against AbbVie's Humira Formulation Patent

    Benzinga | Jun. 29, 2015 | 14:44PM EST
  25. Acquisitions May Fuel Gilead Sciences' Winning Ways

    IBD | Jun. 26, 2015 | 17:28PM EST
  26. Intrexon, Enanta Among Top Biotech New Issues

    IBD | Jun. 24, 2015 | 17:19PM EST
  27. US Stock Futures Slide Ahead Of GDP Data

    Benzinga | Jun. 24, 2015 | 07:13AM EST
  28. AbbVie Reports Phase 3B Results in Genotype 1b Chronic Hep C Patients with Compensated Liver Cirrhosis

    Benzinga | Jun. 24, 2015 | 06:01AM EST
  29. Where Can Mega-Drug Stock Gilead Sciences Go Now?

    IBD | Jun. 22, 2015 | 13:56PM EST
  30. 5 NYSE Healthcare Stocks With The Highest ROE

    Benzinga | Jun. 22, 2015 | 09:29AM EST
  31. The Note Moving Pharma Giants Today

    Benzinga | Jun. 17, 2015 | 16:06PM EST
  32. New Report: Abbvie Is Jefferies' Top Global Pharma Stock

    Benzinga | Jun. 16, 2015 | 12:15PM EST
  33. AbbVie to Present Data from Studies of DUOPA Enteral Suspension in Advanced Parkinson's Disease During the International Congress of Parkinson's Disease and Movement Disorders

    Benzinga | Jun. 12, 2015 | 09:00AM EST
  34. Why Drugmaker AbbVie Can Power Past Patent Expiration

    IBD | Jun. 11, 2015 | 13:13PM EST
  35. Skyworks, Nike Among Big Cap 20 Stocks Pulling Back

    IBD | Jun. 8, 2015 | 18:22PM EST
  36. This Technology Could Disrupt U.S. Pharma Stocks, Credit Suisse Says

    Benzinga | Jun. 8, 2015 | 14:03PM EST
  37. Jefferies Adds AbbVie To Franchise Pick List After Conducting HumiraCo Deep Dive

    Benzinga | Jun. 8, 2015 | 09:32AM EST
  38. Morgan Stanley: Time To Buy Galapagos

    Benzinga | Jun. 8, 2015 | 07:56AM EST
  39. Halozyme Stock Hits New High On AbbVie Collaboration

    IBD | Jun. 3, 2015 | 15:28PM EST
  40. UBS Reviews ASCO, Notes Weekend Data Points From 2 Companies

    Benzinga | Jun. 1, 2015 | 09:38AM EST
  41. Larry Robbins' New Buys During Q1 2015

    GuruFocus | May. 29, 2015 | 19:21PM EST
  42. Gilead Hangs Tough Despite Challenges In Hep C Market

    IBD | May. 29, 2015 | 18:53PM EST
  43. Top Biotech Stock Illumina Hunts For Breakout Gene

    IBD | May. 29, 2015 | 18:31PM EST
  44. Breakout Watch: AbbVie Testing New Buy Point

    IBD | May. 28, 2015 | 11:26AM EST
  45. Morgan Stanley Calls AbbVie 'Unpredictable' With 'Upside'

    Benzinga | May. 28, 2015 | 08:52AM EST
  46. Stock Indexes Rebound Strongly; Microsoft, Intel Lead Blue Chips

    IBD | May. 27, 2015 | 16:17PM EST
  47. 5 Drugs That Could Be Summer Blockbusters

    IBD | May. 27, 2015 | 15:54PM EST
  48. Avago Technologies Breaks Out As Stock Market Rebound Holds

    IBD | May. 27, 2015 | 15:15PM EST
  49. NWQ's First-Quarter Buys and Adds Affect Portfolio

    GuruFocus | May. 26, 2015 | 17:36PM EST
  50. Ambarella Leads 3 Top Stocks Bucking The Sell-Off

    IBD | May. 26, 2015 | 15:20PM EST
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!